Recorded Chinese product: 盐酸舍曲林片盐酸舍曲林片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 辉瑞制药有限公司Chinese legal name: 辉瑞制药有限公司
主要成分Active Ingredients
- 舍曲林Shequ Lin
- 二氯苯基Erlv Benji
- 四氢-N-甲基--萘胺
药物知识说明
舍曲林是一种在国家药监局注册认定的药品。该药品含有二氯苯基、四氢-n-甲基--萘胺、舍曲林-5ea3e3c6等成分。
该药品关联的活性成分包括：二氯苯基Erlv Benji、四氢-n-甲基--萘胺、舍曲林Shequ Lin。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：辉瑞制药有限公司Chinese legal name: 辉瑞制药有限公司。
您可以探索含有相同成分的其他药品：二氯苯基-f0d23bda成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 盐酸舍曲林片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 二氯苯基Erlv Benji, 舍曲林Shequ Lin.
Manufacturers recorded for this product: 辉瑞制药有限公司Chinese legal name: 辉瑞制药有限公司.
Explore other medicines containing the same ingredient: 二氯苯基 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 盐酸舍曲林片Recorded Chinese product: 盐酸舍曲林片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 50mg*14片50 mg × 14 tablets
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 辉瑞制药有限公司Chinese legal name: 辉瑞制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10980141
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10980141
Manufacturer
Chinese legal name: 辉瑞制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10980141
生产企业
辉瑞制药有限公司(国产)
适应症
适用于治疗抑郁症的相关症状。也用于治疗强迫症。
用法用量
口服给药、|1.抑郁症，一次50mg，一日1次，治疗剂量范围为一日50～100mg。|2.强迫症，开始剂量为一次50mg，一日一次，逐渐增加至一日100～200mg，分次口服。
不良反应
1.可有胃肠道不适，如恶心、厌食、腹泻等。|2.可出现头痛、不安、无力、嗜睡、失眠、头晕或震颤等。|3.少见不良反应有过敏性皮疹及性功能减退。|4.大剂量时可能诱发癫痫。|5.突然停药可有撤药综合症，如失眠、焦虑、恶心、出汗、震颤、眩晕或感觉异常等。
禁忌
对本品过敏者禁用。
注意事项
1.闭角型青光眼、癫痫病、严重心脏病患者慎用。|2.肝肾功能不全者慎用或减少用量。|3.出现转向躁狂发作倾向时应立即停药。|4.用药期间不宜驾驶车辆、操作机械或高空作业。
贮藏
密封，置阴凉处。
规格
50mg；14片/盒
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.